Introduction p. ix
Quality of Life p. 1
Comfort p. 1
Pain p. 1
Fatigue p. 3
Pruritus p. 4
Sleep Disturbances p. 5
Dyspnea p. 6
Fever and Chills p. 8
Coping p. 11
Spiritual Distress p. 11
Financial Concerns p. 12
Emotional Distress p. 13
Social Dysfunction p. 15
Loss and Grief p. 16
Anxiety p. 18
Altered Body Image p. 18
Alopecia p. 20
Cultural Issues p. 21
Loss of Personal Control p. 22
Depression p. 23
Survivorship Issues p. 25
Sexuality p. 26
Reproductive Issues p. 26
Sexual Dysfunction p. 28
Symptom Management p. 29
Death and Dying p. 29
Local, State, and National Resources p. 31
Blood Products p. 32
Enteral and Parenteral Nutrition p. 33
Rehabilitation p. 35
Vascular Access Devices p. 36
Pharmacologic Interventions p. 38
Antimicrobials p. 38
Anti-inflammatory Agents p. 39
Antiemetics p. 40
Analgesic Regimens p. 42
Psychotropic Drugs p. 43
Growth Factors p. 44
Answer Explanations p. 46
Protective Mechanisms p. 73
Alterations in Mobility p. 73
Neutropenia p. 76
Thrombocytopenia p. 79
Alterations in Skin Integrity p. 81
Neuropathies p. 84
Alterations in Mental Status p. 87
Infection p. 89
Hemorrhage p. 92
Answer Explanations p. 95
Gastrointestinal and Urinary Function p. 111
Alterations in Nutrition p. 111
Dysphagia p. 111
Anorexia p. 112
Mucositis p. 114
Xerostomia p. 115
Nausea and Vomiting p. 117
Taste Alterations p. 119
Electrolyte Imbalances p. 120
Weight Changes p. 122
Cachexia p. 123
Ascites p. 125
Alterations in Elimination p. 126
Incontinence p. 126
Constipation p. 127
Diarrhea p. 129
Bowel Obstruction p. 130
Ostomies, Urinary Diversions p. 131
Renal Dysfunction p. 133
Answer Explanations p. 134
Cardiopulmonary Function p. 147
Alterations in Ventilation p. 147
Anatomical or Surgical Alterations p. 147
Pulmonary Toxicity Related to Cancer Therapy p. 148
Anemia p. 150
Pleural Effusions p. 152
Alterations in Circulation p. 154
Lymphedema p. 154
Cardiovascular Toxicity Related to Cancer Therapy p. 155
Fluid and Electrolyte Imbalances p. 157
Thrombotic Events p. 158
Answer Explanations p. 160
Oncologic Emergencies p. 169
Metabolic p. 169
Disseminated Intravascular Coagulation p. 169
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) p. 170
Septic Shock p. 171
Acute Tumor Lysis Syndrome p. 172
Anaphylaxis p. 173
Hypercalcemia p. 174
Structural p. 176
Cardiac Tamponade p. 176
Spinal Cord Compression p. 177
Superior Vena Cava Syndrome p. 178
Increased Intracranial Pressure p. 179
Answer Explanations p. 180
Scientific Basis for Practice p. 189
Carcinogenesis p. 189
Specific Cancers p. 191
Pathophysiology p. 191
Diagnostic Measures p. 192
Classification p. 194
Tumor Classification p. 194
Staging p. 195
Grading p. 197
Prognosis p. 198
Major Treatment Modalities p. 200
Surgery p. 200
Radiation p. 201
Biotherapy p. 203
Antineoplastic Agents p. 204
Bone Marrow Transplant p. 205
Immunology p. 207
Genetics p. 208
Answer Explanations p. 209
Health Promotion p. 225
Prevention p. 225
Risk Factors p. 225
Lifestyle p. 225
Environmental p. 226
Occupational p. 227
Health Beliefs p. 228
Prevention Strategies p. 229
Early Detection p. 231
Epidemiology p. 231
Incidence p. 231
Prevalence p. 232
Health History p. 233
Family p. 233
Previous Malignancies p. 234
Previous Cancer Treatment p. 235
Assessment of Risk Factors p. 237
Physical Exam p. 238
Recommendations for Screening p. 239
Answer Explanations p. 240
Professional Performance p. 249
Application of Nursing Standards p. 249
Statement on the Scope and Standards of Oncology Nursing Practice p. 249
Standards of Oncology Education: Patient, Family, and Public p. 250
Research p. 251
Clinical Trials p. 251
Nursing Research Utilization p. 252
Education Process p. 253
Patient p. 253
Family p. 254
Community p. 254
Staff p. 255
Legal Issues p. 256
Ethical Issues p. 256
Patient Advocacy p. 257
Quality Assurance p. 257
Professional Development p. 258
Multidisciplinary Collaboration p. 259
Answer Explanations p. 260